• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铂类化疗在癌症患者肌腱病发病机制中的作用。

The Role of Platinum-Based Chemotherapy in the Pathogenesis of Tendinosis in Cancer Patients.

作者信息

Bisiani Joseph, Lynch Brian

机构信息

Department of Orthopedics, Renaissance School of Medicine, Stony Brook University, Stony Brook, USA.

出版信息

Cureus. 2025 Jul 12;17(7):e87791. doi: 10.7759/cureus.87791. eCollection 2025 Jul.

DOI:10.7759/cureus.87791
PMID:40792345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12339036/
Abstract

Currently, there are numerous anti-cancer drugs to prevent the spread of different neoplasms. Patients who depend on these medications as a form of treatment look to hopefully minimize the spread of cancer. However, there are well-known side effects of platinum-based chemotherapies, such as different electrolyte imbalances. These disturbances could possibly lead to the pathogenesis of tendinosis among cancer patients who take long-term platinum-based chemotherapy treatments, something that has not been thoroughly studied and warrants further investigation. Electrolyte disturbances in tendons can lead to dehydration, which can impair collagen synthesis and ultimately lead to tendon degeneration among cancer patients who are utilizing these long-term platinum cancer drugs.

摘要

目前,有许多抗癌药物可用于预防不同肿瘤的扩散。依赖这些药物进行治疗的患者希望尽可能减少癌症的扩散。然而,铂类化疗存在一些众所周知的副作用,比如不同类型的电解质失衡。这些紊乱可能会导致长期接受铂类化疗的癌症患者发生肌腱病,而这一点尚未得到充分研究,值得进一步调查。肌腱中的电解质紊乱会导致脱水,这会损害胶原蛋白的合成,并最终导致正在使用这些长期抗癌铂类药物的癌症患者出现肌腱退化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b50/12339036/49d79a74a924/cureus-0017-00000087791-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b50/12339036/49d79a74a924/cureus-0017-00000087791-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b50/12339036/49d79a74a924/cureus-0017-00000087791-i01.jpg

相似文献

1
The Role of Platinum-Based Chemotherapy in the Pathogenesis of Tendinosis in Cancer Patients.铂类化疗在癌症患者肌腱病发病机制中的作用。
Cureus. 2025 Jul 12;17(7):e87791. doi: 10.7759/cureus.87791. eCollection 2025 Jul.
2
A systematic overview of chemotherapy effects in ovarian cancer.卵巢癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Platinum-induced hearing loss after treatment for childhood cancer.儿童癌症治疗后铂诱导的听力损失。
Cochrane Database Syst Rev. 2016 Aug 3;2016(8):CD010181. doi: 10.1002/14651858.CD010181.pub2.
7
Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.预防癌症患儿铂类药物所致听力损失的医学干预措施。
Cochrane Database Syst Rev. 2014 Jul 1(7):CD009219. doi: 10.1002/14651858.CD009219.pub3.
8
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
9
Chemotherapy for advanced gastric cancer.晚期胃癌的化疗
Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD004064. doi: 10.1002/14651858.CD004064.pub4.
10
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.

本文引用的文献

1
Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma.重新评估铂类化疗在晚期尿路上皮癌患者不断演变的治疗格局中的作用。
Oncologist. 2024 Dec 6;29(12):1003-1013. doi: 10.1093/oncolo/oyae215.
2
Historical Perspective and Current Trends in Anticancer Drug Development.抗癌药物研发的历史回顾与当前趋势
Cancers (Basel). 2024 May 15;16(10):1878. doi: 10.3390/cancers16101878.
3
Collagen Membrane as Water-Based Gel Electrolyte for Electrochromic Devices.
用于电致变色器件的胶原膜作为水基凝胶电解质
Gels. 2023 Apr 6;9(4):310. doi: 10.3390/gels9040310.
4
Collagen dehydration.胶原脱水。
Int J Biol Macromol. 2022 Sep 1;216:140-147. doi: 10.1016/j.ijbiomac.2022.06.180. Epub 2022 Jul 4.
5
Platinum-based drugs for cancer therapy and anti-tumor strategies.铂类药物用于癌症治疗和抗肿瘤策略。
Theranostics. 2022 Feb 7;12(5):2115-2132. doi: 10.7150/thno.69424. eCollection 2022.
6
Innate and adaptive immune system cells implicated in tendon healing and disease.先天和适应性免疫系统细胞与肌腱愈合和疾病有关。
Eur Cell Mater. 2022 Feb 18;43:39-52. doi: 10.22203/eCM.v043a05.
7
Electrolyte Disorders Induced by Antineoplastic Drugs.抗肿瘤药物引起的电解质紊乱
Front Oncol. 2020 May 19;10:779. doi: 10.3389/fonc.2020.00779. eCollection 2020.
8
Cisplatin-Based Chemotherapy of Human Cancers.基于顺铂的人类癌症化疗
J Cancer Sci Ther. 2019;11(4). Epub 2019 Apr 8.
9
Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.使用日本药品不良事件报告数据库分析铂类化合物相关的肾功能损害不良事件。
SAGE Open Med. 2018 Apr 27;6:2050312118772475. doi: 10.1177/2050312118772475. eCollection 2018.
10
The side effects of platinum-based chemotherapy drugs: a review for chemists.铂类化疗药物的副作用:化学家的综述。
Dalton Trans. 2018 May 15;47(19):6645-6653. doi: 10.1039/c8dt00838h.